Literature DB >> 22099687

2009 influenza A in infants hospitalized at younger than 6 months.

Eduardo Lopez-Medina1, Monica I Ardura, Jane D Siegel, Evangeline Brock, Pablo J Sánchez.   

Abstract

OBJECTIVE: To describe the clinical characteristics and outcomes of infants hospitalized at <6 months of age with 2009 influenza A infection. STUDY
DESIGN: Prospective laboratory surveillance and discharge International Classification of Disease, 9th edition codes for influenza infection were used to identify all infants hospitalized at <6 months of age with positive influenza A tests at Children's Medical Center Dallas from April 27, 2009 to March 23, 2010. Retrospective chart review then was performed.
RESULTS: Seventy-three infants aged <6 months were hospitalized with laboratory-confirmed influenza A infection at a median age of 48 days (range, 3-179 days). The most common clinical characteristics were fever and respiratory signs, and 53% were given a bolus of intravenous fluid. Median length of hospitalization was 2 days (range, 1-162 days). Twenty (27%) infants developed influenza-related complications, including pneumonia (n = 3), hypoxia (n = 18), seizures (n = 2), need for intensive care (n = 8), or death (n = 2). Oseltamivir was administered to 60 (82%) infants and was well tolerated.
CONCLUSIONS: The majority of infants hospitalized with 2009 influenza A had community-acquired infection that was associated with short hospital stays and favorable short-term outcomes. Complications including death occurred, emphasizing the need for preventive strategies. Published by Mosby, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22099687     DOI: 10.1016/j.jpeds.2011.09.060

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  6 in total

1.  Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.

Authors:  David W Kimberlin; Edward P Acosta; Mark N Prichard; Pablo J Sánchez; Krow Ampofo; David Lang; Negar Ashouri; John A Vanchiere; Mark J Abzug; Nazha Abughali; Mary T Caserta; Janet A Englund; Sunil K Sood; Michael G Spigarelli; John S Bradley; Judy Lew; Marian G Michaels; Wen Wan; Gretchen Cloud; Penelope Jester; Fred D Lakeman; Richard J Whitley
Journal:  J Infect Dis       Date:  2012-12-10       Impact factor: 5.226

2.  Influenza hospitalizations in children under 1 year old in Spain: the importance of maternal immunization.

Authors:  Jesús San Román Montero; Ruth Gil-Prieto; Rubén Jiménez Martín; Raúl Ortiz de Lejarazu; Carmen Gallardo-Pino; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2020-12-22       Impact factor: 3.452

3.  Severe Pneumonia Caused by Influenza A (H1N1) Virus Successfully Managed with Extracorporeal Life Support in a Comorbid Former Preterm Infant.

Authors:  Genny Raffaeli; Giacomo Cavallaro; Lorenza Pugni; Ernesto Leva; Andrea Artoni; Simona Neri; Chiara Baracetti; Mauro Cotza; Valerio Gentilino; Leonardo Terranova; Susanna Esposito; Fabio Mosca
Journal:  Int J Environ Res Public Health       Date:  2017-03-31       Impact factor: 3.390

4.  Viral respiratory tract infections in the neonatal intensive care unit: the VIRIoN-I study.

Authors:  Andrea Ronchi; Ian C Michelow; Kimberle C Chapin; Joseph M Bliss; Lorenza Pugni; Fabio Mosca; Pablo J Sánchez
Journal:  J Pediatr       Date:  2014-07-12       Impact factor: 4.406

5.  Intranasal Immunization of Mice to Avoid Interference of Maternal Antibody against H5N1 Infection.

Authors:  Fenghua Zhang; Bo Peng; Haiyan Chang; Ran Zhang; Fangguo Lu; Fuyan Wang; Fang Fang; Ze Chen
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

6.  Viral infections in children with community-acquired pneumonia.

Authors:  Charles R Woods; Kristina A Bryant
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.